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Controlled release formulations have many advantages over immediate release for-
mulations enumerated in the literature, such as less frequent drug administration, lower
plasma peak concentration to avoid adverse effects, and improved patient compliance
(1). Principles of delayed release delivery have lately been applied in developing a ne-
wer version of drug delivery, popularly known as chronotherapeutic drug delivery sys-
tem. Such systems are developed based on the concept of biological/circadian rhythm
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Bearing in mind the present scenario of the increasing
biological tolerance of bacteria against antibiotics, a time
controlled two pulse dosage form of amoxicillin was de-
veloped. The compression coating inlay tablet approach
was used to deliver the drug in two pulses to different
parts of the GIT after a well defined lag time between
the two releases. This was made possible by formulating
a core containing one of the two drug fractions (inten-
ded to be delivered as the second pulse), which was sp-
ray coated with a suspension of ethyl cellulose and a hy-
drophilic but water insoluble agent as a pore former (mi-
crocrystalline cellulose). Coating of up to 5 % (m/m) was
applied over the core tablet, giving a corresponding lag
of 3, 5, 7 and 12 h. Increasing the level of coating led to
retardation of the water uptake capacity of the core, lea-
ding to prolongation of the lag time. Microcrystalline ce-
llulose was used as a hydrophilic but water insoluble po-
rosity modifier in the barrier layer, varying the concen-
tration of which had a significant effect on shortening or
prolongation of the lag time. This coated system was fur-
ther partially compression coated with the remaining
drug fraction (to be released as the first immediate relea-
se pulse) with a disintegrant, giving a final tablet. The
core tablet and the final two pulse inlay tablet were fur-
ther investigated for their in vitro performance.
Keywords: amoxicillin pulsatile drug release, two pulse,
lag time, ethyl cellulose, microcrystalline cellulose
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or chronopharmacological behavior of symptom manifestation of specific conditions
such as asthma, hypertension and allergic rhinitis (1–7). The concept of delivering the
drug in this fashion was earlier restricted to the development of single pulse delivery
systems for achieving maximum concentration in dependence on the symptoms (8). The
concept of delivering the drugs after a well defined lag phase leads to the development
of more than one pulse (multiple pulses) delivery systems. The multiple pulse delivery
system offers advantages over biological resistance to antibiotics. Spore forming bacteria
in the dormant phase are more prone to getting killed (5). The bacterial killing rate via
antibiotics varies at concentrations of around 4 to 5 times the MBC (minimum bacteri-
cidal concentration); high concentrations will not kill bacteria faster than lower concen-
trations at the MIC (minimum inhibitory concentration) value (9–12).
A multiple pulse drug delivery system differs from single pulse chronotherapeutic
delivery in the number of pulses delivered concomitantly with the corresponding num-
ber of lags. The first pulse is an immediate release pulse that begins to dissolve in the
stomach. The subsequent pulses may be designed to provide a lag time followed by
rapid release/delayed release pulses, which may be formulated using sustained or con-
trolled release polymers, depending on the solubility of the drug or the dissolution
properties of the core (4, 6).
EXPERIMENTAL
Materials
Amoxicillin trihydrate (Zest Pharma, India), ethyl cellulose 20 cps (S.D. Fine Chemi-
cals Ltd., India), croscarmellose sodium (Ranbaxy Research Labs., India), sodium starch
glycollate (Ranbaxy Research Labs.), Vivapur PH 102 (directly compressible binder,
MCC grade) (Jubiliant Organosys Noida, India), and magnesium stearate (Central Drug
House, India) were used. All other reagents were of analytical grade and were used as
received.
Formulation of the two pulse release tablet
The two pulse tablet consisted of the following parts: (i) a core containing drug and
disintegrant (second pulse release), (ii) an intermediate coating layer composed of ethyl
cellulose along with a hydrophilic but water insoluble pore former (microcrystalline cel-
lulose) to delay drug release (barrier layer to provide the lag), (iii) an outer compression
coated layer of the second drug fraction over and above the core (first pulse release).
Upon administration via oral route of the two pulse tablet, the first pulse would be
released on reaching the stomach and the next pulse is expected to be released in the in-
testine due to the barrier layer.
Preparation of core tablets. – Direct compression was applied as the primary tabletting
method for compressing the core. Various excipients belonging to the different functio-
nal categories were used during optimization of the formulation composition. Croscar-
mellose sodium was used as a disintegrant based on the swelling index. Core tablets
(composition in Table III) containing one of the drug dose fractions (core tablet dose, 200
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mg amoxicillin), Ac-Di-Sol (5 %, m/m), magnesium stearate (0.5 %, m/m) and Aerosil
(0.5 %, m/m) were prepared by the direct compression method. Weighed amounts of each
ingredient (other than lubricants) were uniformly mixed after sifting through a 0.5 mm
sieve. After 15 minutes of mixing, lubricating agents (pre-sieved through 0.17 mm) were
added and the mixing continued for a further 5 minutes. This tablet mix was transferred
to a sixteen-punch tablet press (Cadmach Machinery, India) having an 8-mm diameter
standard concave punch and die set. The desired tablet mass was achieved by adjusting
the fill volume of the die. The most appropriate compression force was obtained by ad-
justing the dial setting on the tabletting press. Finally, the compression force that was
applied for each tablet formula was determined by performing hardness tests immedi-
ately after fabrication of a few preliminary tablets. Hardness of each tablet was kept wi-
thin a range of 58.8–68.8 N. The tablets were then stored in an airtight polyethylene bag
and protected from moisture until they were coated.
Preparation of coating solution. – The coating solution was prepared by dissolving
ethyl cellulose in isopropyl alcohol (IPA) and dichlomethane (DCM) as solvent in a ratio
of 4:6. Ethyl cellulose was slowly added in the agitating solvent mixture to obtain a clear
solution. Microcrystalline cellulose (MCC) and dibutylphthalate (as a plasticizer) were
further added to the clear polymer solution. MCC is insoluble in the solvent mixture
was kept suspended throughout the coating operation with constant stirring through a
mechanical shaker. The composition of coating solution has been given in Table I.
Coating of core tablets. – The core tablets were coated in a conventional rotating pan
and was done as per the conditions given in Table II. The coating pan was set at an angle
of 45° from the horizontal surface. After continuosly drying the tablets in the rotating
coating pan under hot air, the tablets were further dried in the coating pan for 15 min at
40 °C. The tablets were then placed in a hot air oven for 2 h at 40 °C to remove the sol-
vent traces.
Optimization of lag time of the two pulse drug release system and in vitro analysis. – The
desired lag time of the formulation between the two pulses was set at 3 h. The lag time
of the core tablet was optimized by coating the core with different levels of the coating
solution (1, 2, 3, 4 and 5 %, m/m) and in vitro release behavior was studied. Dissolution
testing was performed in a USP type II apparatus (paddle type) (13) with 75 rpm in 900
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Ethyl cellulose 20 cps 2.25
Vivapur PH 102 0.75
Dibutyl phthalate 0.5
Isopropyl alcohol (40 %) qs
Dichloromethane (60 %) qs
mL phosphate buffer, pH 7.4, at 37 ± 0.5 °C (n = 3). Samples (5 mL) were taken at prede-
termined time intervals and the quantity of drug released was assayed using a UV-spe-
ctrophotometer (Shimadzu UV-1601, double beam, Japan) at 229 nm.
Effect of pore former concentrations. – The concentration of pore former was studied by
coating core tablets keeping the EC concentration of 2.25 % (m/m) and the core tablet
mass build up of 2% as a constant. In addition to the one mentioned above (Table I),
three other coating solutions were prepared by changing the MCC concentration and are
given in Table I.
Preparation of the final two pulse release tablet. – After optimizing the core tablet and
attaining the desired release profile, the final two pulse tablet was prepared in the form
of an inlay or a dot tablet design. The tablet was prepared in a semi automatic manner
by compression coating. The composition of the outer blend (first pulse) release fraction
is given in Table III.
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Table II. Coating conditions employed for pan coating of the core tablet
Parameter Condition
Pan rotation speed (rpm) 25
Inlet air temperature (°C) 45
Bed temperature (°C) 30–34
Atomizing air pressure (Pa) 1.2 ´ 105
Flow rate (mL min–1) 3
Nozzle diameter (mm) 1
To prepare inlay tablet, the bottom of the die cavity was filled with a blend of pre-
-weighed drug (300 mg) and disintegrant, sodium starch glycollate (5 %) and the core
was placed upon it. Due to pushing of the core tablet, the blend got displaced from the
bottom and rearranged in the clearances between the core tablet and die wall, resulting
in coverage of the core tablets from all the sides, except for the top surface. The hardness
of the final tablet was kept in the range of 147–157 N. The pattern of tablet cleavage dur-
ing the hardness test was monitored. The tablet cleaved from the centre without separa-
tion of the core and the surrounding layer. The core tablet (pan coated) and the final two
pulse inlay tablet are displayed in Fig. 1. Drug dose was divided into two parts: core
tablet (200 mg), compression coated drug dose (300 mg). Compression coating over the
core for the two pulse design as high drug loading may not be possible with pan coating
alone. In yet another modification of such a system, the core tablet and the outer drug
fraction blend can be put inside a hard gelatin capsule shell and administered in the
form of a two pulse capsule. A full compression coat (complete coating from all sides) of
the core with the drug fraction could have been applied (instead of coating the core par-
tially/incompletely). This was not done to avoid an additional step in the tablet making
process. For complete compression coating, an additional blend fraction needs to be
weighed for covering the core from the upper side as well.
The tablet when ingested has to face changing body conditions in relation to the
shear, the supply of medium and the pH of the medium. The in-house prepared tablet
being a combination of an immediate release and delayed release component intended
for a specific purpose, was desirable to study the effect of change in the dissolution pH
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ethyl cellulose coated core
final two pulse inlay tabletFig. 1. Photograph showing the amoxicillin
ethyl cellulose coated core and the final two
pulse inlay tablet










Ethyl cellulose (20 cps) 2.25 2.25 2.25 2.25
Vivapur PH 102 0.5 0.75 1.5 2.0
Dibutyl phthalate 0.5 0.5 0.5 0.5
Isopropyl alcohol (40 %) qs qs qs qs
Dichloromethane (60 %) qs qs qs qs
simulating the body conditions. A protocol was designed for that purpose (Table V) with
a set time interval for each dissolution medium in which the tablet was supposed to stay
simulating the body conditions (14).
RESULTS AND DISCUSSION
Influence of the barrier layer on lag time. – Ethyl cellulose was the polymer of choice
for coating along with MCC as a pore former because the combination forms an excel-
lent film suitable for the desired release profile. A significant alteration of the lag time of
drug release from the coated tablets was observed with five levels of coating. Lag time
gets prolonged on increasing the coating level/thickness of core tablets. There was a sig-
nificant alteration in the pulse release after the lag phase in case of coating levels above 3 %.
The release was abrupt or pulse release (or equivalent to immediate release) at 1 % of
coating with no significant lag phase. However, after a lag time of 3 h, the release was
also abrupt with 2 % of coating, but as the coating level increased up to 3 % and above,
the release after the lag phase got slowed down giving a typical controlled release (Fig.
2a). The formulation with 2 % (m/m) coating gave the desired lag time of 3 h. The ratio-
nale of getting the desired lag time of 3 h is that designed two pulse tablets are given
four times a day (each 6 h). This means that the first pulse is immediate release like the
conventional release profile and the expected time to release the drug is about 1.5 h
(300 mg, the first dose to maintain the plasma drug concentration up to MIC and be-
fore the concentration falls below MIC); the next pulse of drug release (lag time, 3 h)
would be furnished in 1.5 h (200 mg). Therefore, the overall time to accomplish the drug
release for one tablet is (1.5 + 3 + 1.5), i.e., 6 h.
Effect of the pore former concentration. – Microcrystalline cellulose was used as a pore
former owing to its properties mentioned above and complementing exactly to the ob-
jective of the study. The concentration of MCC pore former affected drug release, as it is
evident from the release profiles (Fig. 2b). An evident decrease in the lag phase and a
corresponding increase in the drug release were observed with increasing concentra-
tions of MCC (0.5 %, m/m) in the coating solution. This is attributed to fact that MCC
forms fine pores/channels over the tablet surface on contact with water and hence early
exit of the drug from the channels might be possible at higher concentration. However,
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Table V. Protocol for analysis of amoxicillin two pulse tablets
Chronology time Medium pH Simulates
1 h 0.1 mol L–1 HCl (900 mL) 1.2 Stomach (fasting)
+ 15 min Phosphate buffer (500 mL) 6.5 Proximal jejunum
+ 15 min Phosphate buffer (500 mL) 6.8 Distal jejunum
+ 30 min Phosphate buffer (500 mL) 7.2 Proximal ileum
+ 120 min Phosphate buffer (500 mL) 7.5 Distal ileum
Rest of the study Phosphate buffer (500 mL) 6.5 Ascending/transverse colon
while visibly monitoring each tablet during the dissolution, it was observed that in all
the release studies there was no case of premature rupture of the coat from the core and
the core contents squirting out. The integrity of the coat was maintained even when the
contained a hydrophilic component such as MCC. This may be attributed to the water
imbibing capacity of water insoluble MCC.
Rationale for the use of excipients in the coating solution as per the objective of the
study: ethyl cellulose is a pH independent inert polymer, insoluble throughout the GI
tract. It has, however, excellent film forming capabilities and is often used in a variety of
tablets and pellets for providing extended or delayed release coatings. Its controlled or
delayed release function is attributed to its substantially water impermeable nature, sin-
ce it allows very little solvent entry in the core not by its dissolution but through in-
ter-particle pores in the plastic film. In the present study, the desired lag time to be ap-
plied to the core tablet had to be sufficient to prevent the core from breaking in the
initial phase of dissolution in the GIT. For this purpose, EC was the polymer of choice
for providing delayed release characteristics to the tablet.
Since solvent entry in the EC film is very low, to allow the solvent to enter the core,
MCC was used as a pore former due to its special property of being hydrophilic as well
as water insoluble. MCC employed in the concentration mentioned above meets this re-
quirement. The time that the solvent takes to enter inside the core through MCC and the
time that the inner disintegrant (Acdisol) in the core takes to swell to attain the thresh-
old swellability of Acdisol are just sufficient enough to rupture the outer already loos-
ened layer of EC and MCC is the time that forms the lag phase. Some low viscosity
HPMCs (Methocel E-5 and E-15) were evaluated for playing the same role as MCC, but
could not be screened since they solubilized and started releasing the core contents pre-
maturely before the desired lag.
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Fig. 2. Drug release profile with different: a) coating concentrations; b) pore former concentrations
in the coating solution with constant ethyl cellulose coating level of 2 % (m/m), in phosphate buffer,
pH 7.4 (mean ± SD, n = 3).
Effect of dissolution medium pH on lag time
The release obtained in each dissolution medium (0.1 mol L–1 HCl, pH 1.2, phos-
phate buffer, pH 6.5, 6.8, 7.2, 7.5) at the set time intervals was calculated and the plot
was obtained from cumulative release calculations (Fig. 3). Two distinct pulse releases
can be seen in the profile from the in vitro studies. The lag time and hence release profile
remained unaffected by altering the pH of dissolution media. However, a better under-
standing of the concept can be gained after evaluating the developed formulation in vivo,
calculating the drug concentration in plasma and observing the clinical effects.
CONCLUSIONS
The concept of providing two pulses is in its early infancy and promises to go a
long way further due to the increasingly serious issue of biological tolerance. The in-
-house developed formulation successfully demonstrated provision of a two fraction re-
lease of amoxicillin separated by a well defined time controlled lag phase.
A two pulse tablet consisting of a coated core tablet (inner layer) having the com-
pression coating drug (outer layer) of well defined lag time with controlled drug release
was developed. This delivery system is proposed to counter the serious problem of bacte-
rial resistance against antibiotics. Such type of release in spurts has proved to be more
effective in successfully exterminating the microbes with a comparatively low dose com-
pared to the conventional dosage regimens.
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Fig. 3. Drug release from two pulse tablets: outer layer of the tablet constitutes the first pulse, which
released the drug in the stomach within 1 h, the second pulse gave delayed release after a preset lag
time of 3 h in phosphate buffer (mean ± SD, n = 3).
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S A @ E T A K
Dvopulsni sustav za isporuku amoksicilina: Poku{aj
spre~avanja bakterijske rezistencije na antibiotike
HABBAN AKHTER, NITIN SAIGAL, SANJULA BABOOTA, SHAH FAISAL i JAVED ALI
Zbog sve u~estalije pojave rezistencije bakterija na antibiotike, razvijen je dvopulsni
sustav s vremenskom kontrolom za isporuku amoksicilina. Sustav ~ine slojevite tablete s
oblo`enim slojem dobivenim metodom kompresije, koji omogu}avaju isporuku lijeka u
dva pulsa u razli~ite dijelove gastrointestinalnog trakta, s utvr|enom odgodom izme|u
dva osloba|anja. Ovakav na~in osloba|anja postignut je s pripravkom koji u jezgri tab-
lete sadr`i jednu frakciju lijeka (koja se osloba|a kao drugi puls), a u oblozi drugu. Oblo-
`eni dio dobiven je sprejanjem sa suspenzijom etilceluloze i hidrofilnog, ali vodonetop-
ljivog sredstva koji tvori pore (mikrokristalini~na celuloza). Oblaganje sa slojem koji ~ini
1 do 5 % (m/m) mase jezgre postignut je vremenski odmak drugog pulsa od 3, 5, 7 i 12 h.
Pove}anjem mase oblo`nog sloja smanjuje se kapacitet prodiranja vode u jezgru tablete,
{to produljuje vrijeme drugog pulsa. Mikrokristalini~na celuloza uporijebljena je kao hi-
drofilno, vodonetopljivo sredstvo za kotrolu poroznosti u barijernom sloju. Promjena kon-
centracije celuloze zna~ajno je utjecala na skra}enje ili produljenje vremenskog odmaka.
Oblo`eni sustav je potom djelomi~no oblo`en s preostalom frakcijom lijeka (koja se oslo-
ba|a odmah u prvom pulsu) pomije{anom s dezintegratorom. Tableta s jezgrom i dvo-
pulsna slojevita tableta ispitivane su in vitro.
Klju~ne rije~i: amoksicilin, pulsativno osloba|anje lijeka, dva pulsa, vremenski odmak, etilceluloza,
mikrokristalini~na celuloza
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